Quantification of six potential unspecific human biomarkers of 1‐vinyl‐2‐pyrrolidone exposure in Sprague‐Dawley rat urine using gas chromatography coupled with triple mass spectrometry. (1st October 2017)

• Record Type: Journal Article
• Authors: Bertram, J.; Schettgen, T.; Kraus, T.
• Is Part Of: Rapid communications in mass spectrometry. Volume 31:Number 21(2017)
• Page Start: 1851
• Page End: 1858
• Publication Date: 2017-10-01
• Subjects: Mass spectrometry -- Periodicals; 543.65
• DOI: 10.1002/rcm.7972
• Languages: English
• ISSNs: 0951-4198

Abstract

Abstract : Rationale: The monomer 1‐vinyl‐2‐pyrrolidone (VP) is a substance with excellent solvent features. It is used in a wide variety of pharmaceutical, cosmetic, food industrial or technical applications and produced on an industrial scale. Since VP has caused adenocarcinoma of the nasal cavity and liver cell carcinoma in long‐term experiments with rats, a human biomarker would be appreciated for risk assessment. Methods: A sensitive analytical electron ionization gas chromatography/tandem mass spectrometry (GC/MS/MS) method for the determination of six possible biomarkers for VP in urine was established and validated. Two isotope‐labeled internal standards (ISTD) were used for quantification. A simple and easy to use freeze‐drying step was performed prior to derivatization with N ‐ tert ‐butyldimethylsilyl‐ N ‐methyltrifluoracetamide (MTBSTFA) and following sample extraction for cleanup purposes. Results: A calibration curve with six calibration standards ranging from 50 μg/L to 2000 μg/L (10‐fold higher for H‐OPAA) in urine was prepared. Validation results were satisfactory with recoveries ranging from 88.2 to 110.2 % with two exceptions for the lowest quality control for two substances without ISTD (126.4 % and 139.3 %). Three of the substances could be identified as VP metabolites in an exposure study with Sprague‐Dawley (SD) rats. Conclusions: A quick and easy to use method has been established for six target molecules investigated for a better understanding of the metabolism of VP. Two of three substances identified as metabolites of VP could serve as a nonspecific human biomarker for VP exposure as shown with an excerpt of an exposure study performed in SD rats.